Genzyme broadens packaging deal with Hospira; Sigma shareholder slams lower Aspen bid;

@FiercePharma: Top 10 Pharma CEO salaries of 2009. Article | Follow @FiercePharma

> Genzyme, which is attempting to fix quality-control problems involving its top medicines, will have Hospira fill and package the drugs under a new supply agreement between the two companies. Report

> Orbis Australia, one of the biggest shareholders of Sigma Pharmaceuticals, Aspen Pharmacare's 55 cent per share buyout offer was low, and the board should negotiate to get Aspen's earlier, 60 cent per share offer back on the table. Report

> The European Commission cleared German pharmaceutical and chemical company Merck KGaA to buy U.S. laboratory and biotech supply company Millipore for $7.2 billion, including debt. Report

> Novartis has sued the U.S. Patent and Trademark Office, claiming that the agency's interim method for recalculating patent term adjustments in light of Wyeth v. Kappos has effectively cut short 11 of the drugmaker's patents. Report

> Takeda Pharmaceutical will set aside 50 billion yen ($569 million) annually for the next three years to buy new products. Report

> Profit at GlaxoSmithKline Pakistan, the country's largest drugmaker, is being hurt by a weakening rupee and conflict in the northwest, and the government should deregulate prices to help, the company's chief executive says. Report

> Global sales of HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, Datamonitor Group says. Report

> Allergan has named Douglas Ingram as the new chief of its Europe, Africa, and Middle East unit, beginning Aug. 1. Report

Biotech News

@FierceBiotech: XenoPort's lead program suffers another big setback. Article | Follow @FierceBiotech

@JohnCFierce: Fewer IPOs, smaller VC funds. Lean and mean will be the dominant fashion for Venrock's new, smaller fund. Article | Follow @JohnCFierce

> Sanofi adding 300 workers in $65M Boston HQ expansion. News

> NIH chief lobbies for $500M fund to back clinical trials. Item

> Infinity inks $488M pact on Intellikine's PI3K portfolio. Report

Vaccine News

> Dynavax launches first human trial of universal flu vax. Article

> Group wants investigation into Sanofi, Merck contracts. Story

> Intercell scrambles after vax patch flunks PhII. Report

> Smallpox vaccinia virus spread by physical contact. Item

Manufacturing News

> GSK taps Singapore for green manufacturing ops. Story

> Abu Dhabi to deploy drug track/trace system. News

> India continues rise a global drug power. Report

> Girindus wins process validation contract. Article

> Nigeria takes on fake drugs with new tech. Item

> Drug manufacturing jobs moving to India. Article

And Finally... They may contain zero calories, no sugar and provide an energy boost, but diet soda could drain calcium and phosphorous from your body, according to a preliminary study presented at a medical convention. Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.